mims
Apr 20, 2018
Why a niche pharma publisher is getting business from BMW
As revenue from blockbuster drugs dries up, brands and media in the pharma space have had to adjust. Sherlynn Tan of Singapore-based MIMS explains what one media owner has done.
Top news, insights and analysis every weekday
Sign up for Campaign Bulletins
.jpg&h=334&w=500&q=100&v=20170226&c=1)
.jpeg&h=334&w=500&q=100&v=20170226&c=1)
.jpg&h=334&w=500&q=100&v=20170226&c=1)
.png&h=334&w=500&q=100&v=20170226&c=1)
.png&h=334&w=500&q=100&v=20170226&c=1)
.jpg&h=334&w=500&q=100&v=20170226&c=1)